Seroprevalence of Autoantibodies against Brain Antigens in Health and Disease
Seroprevalence of Autoantibodies against Brain Antigens in Health and Disease
复制标题
DOI:
10.1002/ana.24189
复制
发表时间:
2014-07-01
影响因子:
11.2
通讯作者:
Ehrenreich, Hannelore
中科院分区:
文献类型:
--
作者:
Dahm, Liane;Ott, Christoph;Ehrenreich, Hannelore
Objective: We previously reported an unexpectedly high seroprevalence (similar to 10%) of N-methyl-D-aspartate-receptor subunit-NR1 (NMDAR1) autoantibodies (AB) in healthy and neuropsychiatrically ill subjects (N = 2,817). This finding challenges an unambiguous causal relationship of serum AB with brain disease. To test whether similar results would be obtained for other brain antigen-directed AB previously connected with pathological conditions, we systematically screened serum samples of 4,236 individuals.Methods: Serum samples of healthy (n = 1,703) versus neuropsychiatrically ill subjects (schizophrenia, affective disorders, stroke, Parkinson disease, amyotrophic lateral sclerosis, personality disorder; total n = 2,533) were tested. For analysis based on indirect immunofluorescence, we used biochip mosaics of frozen brain sections (rat, monkey) and transfected HEK293 cells expressing respective recombinant target antigens.Results: Seroprevalence of all screened AB was comparable in healthy and ill individuals. None of them, however, reached the abundance of NMDAR1 AB (again similar to 10%; immunoglobulin [Ig] G similar to 1%). Appreciable frequency was noted for AB against amphiphysin (2.0%), ARHGAP26 (1.3%), CASPR2 (0.9%), MOG (0.8%), GAD65 (0.5%), Ma2 (0.5%), Yo (0.4%), and Ma1 (0.4%), with titers and Ig class distribution similar among groups. All other AB were found in